Point72 Middle East FZE »

Mersana Therapeutics shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $59k 26k 2.32
2023-09-30 $31k 24k 1.27
2023-03-31 $66k 16k 4.11
2022-12-31 $56k 9.6k 5.86

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Mersana Therapeutics

EcoR1 Capital
VR Adviser
Balyasny Asset Management
Vanguard Group
Nextech Invest
Millennium Management
Citadel Advisors
5AM Venture Management
Schonfeld Strategic Advisors
Deutsche Bank Aktiengesellschaft
Baker Bros. Advisors
Jacobs Levy Equity Management
D. E. Shaw & Co
Bank of New York Mellon
Jane Street

View all funds holding Mersana Therapeutics